CSPC Innovation Stock Hits Day Low of CNY 25.01 Amid Price Pressure

CSPC Innovation Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 4.58% and reaching an intraday low of CNY 25.01. This performance marks a stark contrast to the China Shanghai Composite, which saw a slight increase of 0.12% on the same day. Over the past week, CSPC has faced a 9.33% decrease, and its one-month performance shows a decline of 13.6%. Year-to-date, the stock has fallen by 27.81%, while the broader market has gained 3.27%. The company's long-term growth prospects appear concerning, as it has reported negative results for the last ten consecutive quarters. Key financial metrics indicate a return on capital employed (ROCE) of -9.81% and a net profit of CNY -95.43 million, reflecting a significant drop of 47.33%. CSPC's inventory turnover ratio stands at a low 3.51 times, and the stock is currently trading at a high price-to-book ratio of 16.77. With a market capitalization of CNY 43,219 million, CSPC Innovation Pharmaceutical continues to face challenges in its financial performance amidst a fluctuating market environment.